NCT07587229 Alternative Splicing Based Prediction of Chemotherapy Response in Gastric Cancer
| NCT ID | NCT07587229 |
| Status | Recruiting |
| Phase | — |
| Sponsor | City of Hope Medical Center |
| Condition | Gastric Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 329 participants |
| Start Date | 2026-05-01 |
| Primary Completion | 2027-01-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 329 participants in total. It began in 2026-05-01 with a primary completion date of 2027-01-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to develop a model to predict response to chemotherapy in gastric cancer using RNA splicing information from tumor tissue. By analyzing genetic patterns and applying machine learning, the study seeks to identify patients who are less likely to benefit from treatment, helping guide clinical decision-making.
Eligibility Criteria
Inclusion Criteria: * Pathologically confirmed stage II or III gastric cancer * Underwent curative surgical resection * Received 5-FU-based adjuvant chemotherapy * Availability of tumor tissue samples for analysis Exclusion Criteria: * History of other malignancies * Inadequate or poor-quality tissue samples (e.g., contamination)
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07587229 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Gastric Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07587229 currently recruiting?
Yes, NCT07587229 is actively recruiting participants. Contact the research team at ajgoel@coh.org for enrollment information.
Where is the NCT07587229 trial being conducted?
This trial is being conducted at Duarte, United States.
Who is sponsoring the NCT07587229 clinical trial?
NCT07587229 is sponsored by City of Hope Medical Center. The trial plans to enroll 329 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.